Also, some have chosen to stay with the doses they have been using, at least until they see the full justification or the 300 mg recommendation, data which may not be published for several months. The new official recognition for aerosol pentamidine should make it easier to get insurance companies to pay for the treatment. Another benefit of the treatment IND is that research protocols will probably be changed to allow patients to use aerosol pentamidine, if they do not already do so. And the U.S. approval may contribute to efforts to make aerosol pentamidine available in Canada , where lack of access has been a major problem. LyphoMed has agreed to continue trials of aerosol pentamidine for 24 months, even after full FDA approval, so some patients will receive free treatment through this study.
Physicians can request an enrollment packet with forms and instructions.
Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. Includes early delivery of an extra copy by email. Includes early delivery of an extra copy by email. If you cannot afford a subscription, please write or call.